相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Simulations of site-specific target-mediated pharmacokinetic models for guiding the development of bispecific antibodies
Vaishali L. Chudasama et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2015)
Quantitative Prediction of Human Pharmacokinetics for mAbs Exhibiting Target-Mediated Disposition
Aman P. Singh et al.
AAPS JOURNAL (2015)
A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study design
Jasmine P. Davda et al.
MABS (2014)
Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model
Joanne Brodfuehrer et al.
PHARMACEUTICAL RESEARCH (2014)
Implementation of pharmacokinetic and pharrnacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research
Tove Tuntland et al.
FRONTIERS IN PHARMACOLOGY (2014)
Modeling, Simulation, and Translation Framework for the Preclinical Development of Monoclonal Antibodies
Kenneth T. Luu et al.
AAPS JOURNAL (2013)
pSTAT3: a target biomarker to study the pharmacology of the anti-IL-21R antibody ATR-107 in human whole blood
Ming Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Antibody biodistribution coefficients Inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human
Dhaval K. Shah et al.
MABS (2013)
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
Paul Morgan et al.
DRUG DISCOVERY TODAY (2012)
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human
Dhaval K. Shah et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
Theoretical Considerations of Target-Mediated Drug Disposition Models: Simplifications and Approximations
Peiming Ma
PHARMACEUTICAL RESEARCH (2012)
A Model-Based Approach to Predicting the Human Pharmacokinetics of a Monoclonal Antibody Exhibiting Target-Mediated Drug Disposition
Kenneth T. Luu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
On Setting the First Dose in Man: Quantitating Biotherapeutic Drug-Target Binding through Pharmacokinetic and Pharmacodynamic Models
Philip J. Lowe et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
Nathanael L. Dirks et al.
CLINICAL PHARMACOKINETICS (2010)
Development of a PBPK Model for Monoclonal Antibodies and Simulation of Human and Mice PBPK of a Radiolabelled Monoclonal Antibody
Tomi Heiskanen et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Target site occupancy: Emerging generalizations from clinical and preclinical studies
Sarah Grimwood et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Population pharmacokinetic/pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients
Maria C. Rosario et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and Anti-HIV activity of aplaviroc
James F. Demarest et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Approximations of the target-mediated drug disposition model and identifiability of model parameters
Leonid Gibiansky et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2008)
Measuring drug-related receptor occupancy with positron emission tomography
J Passchier et al.
METHODS (2002)
General pharmacokinetic model for drugs exhibiting target-mediated drug disposition
DE Mager et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
分享论文
